MiR-582-3p is available to target DLX2 to repress HCC's development, and miR-582-3p in HCC cell line Huh-7 and HCCLM3 is silenced vs. the normal hepatocytes [39]. This evidence concerns the gene DLX2 and hepatocellular carcinoma.